The following is a summary of “Factors Affecting Risk of CVD Events in a Global CVD Prevention Cohort of People with HIV,” published in the April 2025 issue of Clinical Infectious Diseases by Grinspoon et al. Researchers conducted a retrospective study to examine the elevated risk of major adverse cardiovascular disease (MACE) among people with